“According to BCC Research, the global outpatient surgical procedures market is projected to grow from $381.9 billion in 2026 to $598.6 billion by 2031, at a CAGR of 9.4%, as healthcare delivery continues to shift toward efficient outpatient surgical settings.”

Boston, Sept. 11, 2026 (GLOBE NEWSWIRE) -- The global outpatient surgical procedures market is projected to grow from $353.2 billion in 2025 to $598.6 billion by 2031, at a compound annual growth rate (CAGR) of 9.4% during 2026–2031, according to BCC Research's newly published report, Outpatient Surgical Procedures: Global Markets. BCC Research identifies structural shifts in surgical care delivery — anchored by demographic pressure, technological innovation, and policy realignment — as the central forces reshaping this high-growth sector.

Key Findings

• The global outpatient surgical procedures market is forecast to reach $598.6 billion by 2031, expanding at a 9.4% CAGR from 2026 to 2031, underpinned by accelerating migration of complex procedures from hospital inpatient settings to ambulatory surgical centers (ASCs) and outpatient facilities, driven by measurable cost and recovery advantages.
• North America is the dominant regional market, valued at $204.1 billion in 2025, reflecting the region's established ASC infrastructure, aggressive reimbursement expansion under Medicare, and high rates of chronic disease conditions requiring planned surgical intervention.
• The rising prevalence of chronic diseases — including cardiovascular disease, cancer, diabetes, and arthritis — is generating sustained, predictable demand for outpatient surgical interventions, as health systems seek scalable alternatives to inpatient care to manage growing patient volumes without proportionate capacity expansion.
• ASC procedural costs are typically approximately 50% lower than traditional hospital settings, creating compelling financial incentives for payers, governments, and patients alike, and accelerating policy-driven volume shifts across orthopedics, cardiology, and spine surgery specialties.
• Emerging technologies including histotripsy (incisionless ultrasound surgery), robotic surgical systems, minimally invasive cardiovascular devices, laparoscopic and advanced endoscopic surgery, and CAR T-cell therapy outpatient management models are materially expanding the procedural scope feasible in non-hospital settings, transforming what was once exclusively inpatient territory.
• Key market participants include AMSURG, Surgery Partners, United Surgical Partners International, Optum Inc., HCA Healthcare, Kaiser Foundation Health Plan Inc., Mayo Foundation for Medical Education and Research, Cleveland Clinic, Johns Hopkins Medicine, IHH Healthcare Berhad, and Helios Kliniken GmbH (Fresenius Helios), among others.

Market Drivers

Two structural forces are converging to make outpatient surgical care one of healthcare's most compelling growth segments. First, demographic inevitability: an aging global population carries disproportionately higher rates of chronic conditions requiring elective surgical intervention. Older patients increasingly favor minimally invasive outpatient procedures due to shorter recovery times, reduced physical trauma, and the avoidance of hospital stays — aligning patient preference with system-level cost objectives. Second, a supportive policy environment is accelerating adoption. The 2020 expansion of Medicare coverage to include percutaneous coronary intervention (PCI) in ASC settings exemplifies a broader regulatory trend, with governments and national insurers progressively extending reimbursement frameworks to outpatient settings across specialties. Simultaneously, large healthcare systems and specialized operators are rapidly expanding ASC facility networks, broadening geographic access and absorbing growing procedural demand.

Investment Considerations

For investors, the outpatient surgical procedures market presents a structurally compelling opportunity defined by durable demand tailwinds, favorable unit economics, and expanding technological enablement. Operators with scaled ASC networks — particularly those exposed to high-growth specialties such as cardiology, orthopedics, and spine surgery — are best positioned to capture margin expansion as procedure mix complexity increases. Key risks include escalating healthcare staffing and labor costs, which threaten the cost differential that underpins the outpatient value proposition, as well as regulatory fragmentation across international markets that complicates cross-border scaling. Investors should also monitor the pace of reimbursement policy evolution, as coverage expansions remain a direct volume catalyst in major markets.

About the Report

Outpatient Surgical Procedures: Global Markets provides comprehensive market sizing, segmentation by procedure type and setting, competitive intelligence across leading global operators, and a full forecast period spanning 2026 to 2031.

About BCC Research

BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts assess growth trends, identify and evaluate new and changing market opportunities, and provide critical information and innovative decision support tools to help inform the strategic decision-making process.
For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

CONTACT: BCC Research LLC
50 Milk St., Ste. 16, Boston, MA 02109
press@bccresearch.com  |  +1 781-489-7301
www.bccresearch.com